Pfizer has obtained the European Commission approval for the use of Prevenar 13 vaccine in older children and adolescents aged six to 17 years for the prevention of pneumococcal disease. Single dose of the pneumococcal conjugate vaccine ...
Tags: vaccine, Pfizer, pneumococcal disease, medicines
Increasing demand and the need for shorter development times are convincing vaccine manufacturers to switch from traditional egg-based production to advanced mammalian cell-culture fermentation.Efficient fermentation requires careful ...
Tags: mammalian, dissolved oxygen, pH, Bioreactor
New solutions provide complete protection against all kinds of threats with minimum impact on PC performance thanks to their cloud technologies The new Scan Manager scans up to 70 percent faster BERKSHIRE, ENGLAND, September 09, 2012 ...
Tags: Panda Security, Computer Products, Consumer Antivirus Solutions
Synthetic Biologics and Intrexon have commenced development of a monoclonal antibody (mAb) therapy, SYN-005, to treat pertussis, commonly known as whooping cough. To manage the rising number of pertussis cases, Synthetic Biologics intends ...
Tags: Synthetic Biologics, monoclonal antibody therapy, whooping cough
Nuron Biotech has secured $80m finance from HealthCare Royalty Partners to support the commercialization and expansion of its Meningitec, a recently acquired vaccine from Pfizer. Meningitec is an established commercial vaccine to prevent ...
Tags: Nuron Biotech, secured finance, vaccine, Meningitec, commercial vaccine
Microsoft may have known about last week's Internet Explorer (IE) zero-day bug for some time, according to its security advisory. The vulnerability, which was patched Friday in an emergency, or "out-of-band," update, first became public ...
Tags: Microsoft, IE, bug, vulnerability
GlycoVaxyn and GlaxoSmithKline Biologicals(GSK)have signed a research partnership for the development of new bacterial vaccines. The collaboration,planned for three years,will leverage GlycoVaxyn's bio-conjugation technology in developing ...
Tags: GSK, Glycovaxyn, bacterial vaccines, Partnership
LOCAL shares rose for the third straight day today, hitting a fresh 17-month high as investors sought defensive and higher-yielding stocks as concern grew over the fate of US negotiations on the so-called fiscal cliff. The benchmark ...
GlaxoSmithKline (GSK) has announced the FDA approval of four-strain seasonal influenza (flu) virus vaccine, Fluarix Quadrivalent, to immunize adults and children of three years age and more, in the US. The intramuscular vaccine is ...
Biopharma and vaccine manufacturing company Cellon’s entire range of PharmaTainer bottles and carboys are now certified ‘clean,’ and meet USP 788 Particulate Matter in Injections as well as the equivalent EP and JP quality ...
Tags: Cellon, PharmaTainer bottle, packaging, packaging products
The Sanofi vaccines division Sanofi Pasteur has launched Japanese encephalitis (JE) vaccine, IMOJEV, in Australia. Australian Health Authorities approved the live-attenuated JE vaccine for people aged 12 months and older, based on data ...
Tags: Australian Health Authorities, Japanese encephalitis, vaccine, JE vaccine
(i)Policy and Administrative Rules Catalogue of Related Laws Foreign Trade Law of the People's Republic of China Customs Law of the People's Republic of China Law of the People's Republic of China on Import and Export Commodity ...
Tags: jiangsu province, survey, economy, investment
Fraunhofer Center for Molecular Biotechnology (FhCMB) has received a contract from the US National Institute of Allergy and Infectious Diseases to develop vaccine technologies for advancing the next generation of anthrax vaccines. ...
Tags: FhCMB, anthrax vaccines, NIH
Inovio Pharmaceuticals has received a US patent covering SynCon vaccine for cervical dysplasias and cancers caused by human papillomavirus (HPV). The patent covers Inovio's synthetic consensus HPV antigens, DNA constructs and vaccines ...
Tags: Inovio Pharmaceuticals, SynCon vaccine, HPV
Bexsero, Novartis' Meningococcal Group B Vaccine, has won a positive opinion from European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). The CHMP opinion indicates the use of the broad coverage vaccine in ...